• Profile
Close

Role of Interleukin-35 in sublingual allergy immunotherapy

The Journal of Allergy and Clinical Immunology Jul 30, 2018

Shamji MH, et al. - Authors gauged the mechanisms underlying the induction and maintenance of immunological tolerance induced by IL-35 and iTR35 cells. Findings suggested that potential novel immune-regulators induced by sublingual immunotherapy (SLIT) were IL-35 and iTR35 cells. There was a possibility of the restoration of protective iTR35 cells to underscore the clinical relevance of SLIT. Th2 cell proliferation and cytokine production were suppressed by iTR35 cells.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay